AS03 (for "Adjuvant System 03") is the trade name for a squalene-based immunologic adjuvant used in various vaccine products by GlaxoSmithKline (GSK).... 3 KB (324 words) - 20:40, 19 July 2023 |
United States Military Academy". 1986. https://docs.house.gov/meetings/AS/AS03/20180419/108073/HHRG-115-AS03-Bio-AndersonJ-20180419.PDF [bare URL PDF]... 11 KB (116 words) - 13:25, 10 February 2023 |
Ouhoummane, Najwa (2012-07-03). "Short and Long-Term Safety of the 2009 AS03-Adjuvanted Pandemic Vaccine". PLOS ONE. 7 (7): e38563. Bibcode:2012PLoSO... 24 KB (2,510 words) - 20:19, 13 April 2024 |
of Authority". DVIDS. https://docs.house.gov/meetings/AS/AS03/20210503/112544/HHRG-117-AS03-Bio-OlsonG-20210503.pdf [bare URL PDF] "Brigadier General... 4 KB (171 words) - 15:06, 14 May 2023 |
FLUAD, have been administered with no severe adverse effects reported. AS03 is another squalene-containing adjuvant. The plant extract QS-21 is a liposome... 37 KB (4,220 words) - 10:13, 27 March 2024 |
Gaon Panchayat, Jhanji Hanhchara, Tamulisiga, Jarabari Languages • Official Assamese Time zone UTC+5:30 (IST) PIN 785683 Vehicle registration AS04, AS03... 5 KB (312 words) - 08:47, 5 March 2023 |
aluminium hydroxide and monophosphoryl lipid A (MPL). It is the successor of AS03, a squalene based adjuvant used in H1N1/09 and H5N1 influenza vaccines. Studies... 13 KB (1,202 words) - 18:58, 27 December 2023 |